European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Activating β2-adrenergic receptor is a potential cross-disease therapeutic strategy for Alzheimer's disease, obesity and type 2 diabetes.
Ruonan Zhou, Mengli Luo, Jiaxin Lv, Wenbin Shang
Published: 202610.1016/j.euroneuro.2025.11.006
No abstract available for this study.